| Clinical data | |
|---|---|
| Other names | 4‑MEAP; 4‑MEAPP;N-Ethyl-4'-methylnorpentedrone; 2-(Ethylamino)-1-(4-methylphenyl)-1-pentanone; 4-Methyl-alpha-ethylaminopentiophenone; 4‑methyl‑NEP |
| Legal status | |
| Legal status | |
| Identifiers | |
| |
| CAS Number |
|
| PubChemCID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C14H21NO |
| Molar mass | 219.328 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
4-Methyl-α-ethylaminopentiophenone (4-MEAP) is adesigner drug of thecathinone class.[2][3] It is a higherhomolog of4-methylpentedrone (4-MPD) with anethyl group in place of themethyl group. 4-MEAP has been found in samples of drugs sold as 4-MPD.[4]
In the United States, 4-MEAP is aSchedule I Controlled Substance.[5][6]